October 24, 2022
1 min read
In August, the U.S. Preventive Services Task Force published a statement recommending statins for the primary prevention of CVD in patients aged 40 to 75 years with at least one CVD risk factor and 10% or greater 10-year risk for CVD.
Experts said the USPSTF recommendation excludes many patients who would otherwise likely benefit from statin therapy by concluding that it has a moderate net benefit in individuals with at least 10% 10-year atherosclerotic CVD risk (ASCVD) and small net benefit in those with a 7.5% to 10% 10-year ASCVD risk. It was the top story in cardiology last week.
The second top story was about the American Heart Association’s updated Life’s Essential 8 risk calculator, which now includes sleep as a cardiovascular health metric to predict CVD incidence. A new study suggests that this update may enhance CVD primordial and primary prevention efforts.
Read these and more top stories in cardiology below:
Lost opportunities for prevention if clinicians adopt USPSTF statin recommendations
The U.S. Preventive Services Task Force in August published a statement regarding the initiation of statin therapy for the primary prevention of atherosclerotic CVD. Read more.
Addition of sleep metric in updated Life’s Essential 8 predicts CVD incidence
The incorporation of sleep as a cardiovascular health metric, as recently done with the American Heart Association’s updated Life’s Essential 8 risk calculator, may enhance CVD primordial and primary prevention efforts, data show. Read more.
Higher BMI tied to early AF risk in young men
Increasing BMI in young adult men is strongly associated with early atrial fibrillation as well as later worse clinical outcomes, including incident heart failure, stroke and all-cause mortality, among those diagnosed with atrial fibrillation, researchers reported. Read more.
CVD risk factors confer elevated risk for mortality in severe COVID-19
CVD risk factors were associated with mortality in patients hospitalized for COVID-19, but preexisting CVD was not, researchers reported in Circulation: Cardiovascular Quality and Outcomes. Read more.
Black patients less likely to receive VADs, heart transplants than white patients
Among adults with advanced heart failure, Black patients were less likely than white patients to receive a ventricular assist device or a heart transplant, according to the results of the REVIVAL prospective cohort study. Read more.